Your browser doesn't support javascript.
loading
Duration of neuromuscular block is more variable and recovery time is shorter with rocuronium than cisatracurium in anesthetized dogs.
Martin-Flores, Manuel; Hackman, Megan C; Araos, Joaquin D; Campoy, Luis; Gleed, Robin D.
Afiliação
  • Martin-Flores M; Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY, USA.
  • Hackman MC; Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY, USA.
  • Araos JD; Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY, USA.
  • Campoy L; Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY, USA.
  • Gleed RD; Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, NY, USA.
Vet Ophthalmol ; 26(5): 407-413, 2023 Sep.
Article em En | MEDLINE | ID: mdl-36799561
ABSTRACT

OBJECTIVE:

To compare the variability in the duration of action of a single dose of rocuronium or cisatracurium, and duration of subsequent top-up doses in anesthetized dogs. ANIMALS Thirty dogs requiring ophthalmic surgery with neuromuscular block. PROCEDURES Neuromuscular function was monitored with train-of-four (TOF) and acceleromyography. Dogs received an initial dose of rocuronium 0.6 mg/kg, or cisatracurium 0.15 mg/kg IV, which produced complete neuromuscular block. Upon return of the first response (T1) of TOF, a third of the initial dose was repeated. The duration of the initial dose and its variability were compared between agents. Duration of subsequent top-up doses was assessed with mixed effect models. Spontaneous (from last return of T1) or neostigmine-enhanced (from administration to complete recovery) recovery times were measured for each agent.

RESULTS:

Duration of action of the initial dose was [median (range)] 25 (10-60) min with rocuronium and 35 (15-45) min with cisatracurium (p = .231). The variability of rocuronium was 3.25 times larger than cisatracurium (p = .034). Duration of top-up doses did not vary for either agent. Spontaneous recovery was shorter for rocuronium [15 (10-20) min] than cisatracurium [25 (15-45) min] (p = .02). Neostigmine-enhanced recovery times were 5 (5-25) for rocuronium and 10 (5-10) for cisatracurium (p = .491).

CONCLUSIONS:

Duration of action for a single dose is significantly more variable with rocuronium than cisatracurium. Time to spontaneous recovery was longer for cisatracurium, and cases of unexpectedly long recovery times were observed with both agents. Objective monitoring is recommended.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fármacos Neuromusculares não Despolarizantes / Bloqueio Neuromuscular Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Vet Ophthalmol Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fármacos Neuromusculares não Despolarizantes / Bloqueio Neuromuscular Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Vet Ophthalmol Ano de publicação: 2023 Tipo de documento: Article